# Malcolm V. Brock

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/malcolm-v-brock/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,187 |
| Field | Epigenetics and DNA Methylation |
| h-index | 70 |
| i10-index | 178 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5108625768 |
| Works | 479 |

## Researcher papers

- [Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer](https://scholariq.org/papers/comprehensive-genomic-analysis-identifies-sox2-as-a-frequently-amplified-gene-in/)
- [Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer](https://scholariq.org/papers/dysfunctional-keap1-nrf2-interaction-in-non-small-cell-lung-cancer/)
- [Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer](https://scholariq.org/papers/evolution-of-neoantigen-landscape-during-immune-checkpoint-blockade-in-non-small/)
- [Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers](https://scholariq.org/papers/transcriptional-programs-of-neoantigen-specific-til-in-anti-pd-1-treated-lung/)
- [Epigenetic therapy inhibits metastases by disrupting premetastatic niches](https://scholariq.org/papers/epigenetic-therapy-inhibits-metastases-by-disrupting-premetastatic-niches/)
- [Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer](https://scholariq.org/papers/neoadjuvant-nivolumab-plus-ipilimumab-in-resectable-non-small-cell-lung-cancer/)

## Researcher topics

- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer-related gene regulation](https://scholariq.org/topics/cancer-related-gene-regulation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.